Authors
Arun Njanappilly Madhavana
a. Department of Internal Medicine, Quality Clinic, Palakkad, Kerala
Abstract
JAK inhibitors are a drug class that is showing promising clinical outcomes in a variety of conditions. This review article is about Tofacitinib the most frequently prescribed drug among JAK inhibitors.
Keywords: Tofacitinib, Autoimmune diseases, Indications